Safety of Sildenafil in Premature Infants

Completed · Phase 2 · Has a placebo group

Conditions studied: Bronchopulmonary Dysplasia

In brief

Describe the safety of sildenafil in premature infants at risk of bronchopulmonary dysplasia and determine preliminary effectiveness and pharmacokinetics (PK) of sildenafil. Funding Source - FDA Office of Orphan Products Development (OOPD).

Key facts

Study ID
NCT03142568
Run by
University of North Carolina, Chapel Hill
People needed
109
Starts
2018-04-02
Expected to finish
2025-03-01
Last updated by the study team
2026-03-30

Who can join

Age: 0 and older, up to 0. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.